Your browser doesn't support javascript.
loading
Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution.
Furlan, Anna; Rossi, Maria Cristina; Gherlinzoni, Filippo; Scotton, Piergiorgio.
Affiliation
  • Furlan A; Hematology Unit, Azienda ULSS2 Marca Trevigiana, 31100 Treviso, Italy.
  • Rossi MC; Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, 31100 Treviso, Italy.
  • Gherlinzoni F; Hematology Unit, Azienda ULSS2 Marca Trevigiana, 31100 Treviso, Italy.
  • Scotton P; Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, 31100 Treviso, Italy.
Hematol Rep ; 14(2): 135-142, 2022 Apr 13.
Article de En | MEDLINE | ID: mdl-35466184

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Hematol Rep Année: 2022 Type de document: Article Pays d'affiliation: Italie Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Hematol Rep Année: 2022 Type de document: Article Pays d'affiliation: Italie Pays de publication: Suisse